- Home
- SPPP vs TLSA Comparison
SPPP vs TLSA Comparison
Compare SPPP & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPP
- TLSA
- Stock Information
- Founded
- SPPP 2011
- TLSA 2013
- Country
- SPPP Canada
- TLSA United Kingdom
- Employees
- SPPP N/A
- TLSA N/A
- Industry
- SPPP
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- SPPP
- TLSA Health Care
- Exchange
- SPPP NYSE
- TLSA Nasdaq
- Market Cap
- SPPP 172.2M
- TLSA 187.0M
- IPO Year
- SPPP N/A
- TLSA 2000
- Fundamental
- Price
- SPPP $12.95
- TLSA $1.48
- Analyst Decision
- SPPP
- TLSA
- Analyst Count
- SPPP 0
- TLSA 0
- Target Price
- SPPP N/A
- TLSA N/A
- AVG Volume (30 Days)
- SPPP 183.3K
- TLSA 186.3K
- Earning Date
- SPPP 01-01-0001
- TLSA 07-29-2025
- Dividend Yield
- SPPP N/A
- TLSA N/A
- EPS Growth
- SPPP N/A
- TLSA N/A
- EPS
- SPPP N/A
- TLSA N/A
- Revenue
- SPPP N/A
- TLSA N/A
- Revenue This Year
- SPPP N/A
- TLSA N/A
- Revenue Next Year
- SPPP N/A
- TLSA N/A
- P/E Ratio
- SPPP N/A
- TLSA N/A
- Revenue Growth
- SPPP N/A
- TLSA N/A
- 52 Week Low
- SPPP $8.55
- TLSA $0.63
- 52 Week High
- SPPP $11.39
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- SPPP 66.96
- TLSA 50.51
- Support Level
- SPPP $11.57
- TLSA $1.43
- Resistance Level
- SPPP $12.68
- TLSA $1.54
- Average True Range (ATR)
- SPPP 0.28
- TLSA 0.07
- MACD
- SPPP 0.05
- TLSA -0.01
- Stochastic Oscillator
- SPPP 77.97
- TLSA 47.22
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.